---
title: "Final Update Antipsychotics Project"
subtitle: "I´m so glad &#x1F602;&#x1F44F;"
format: 
  revealjs:
    theme: [default, custom.scss]
    slide-number: true
incremental: true
editor: source
---

## Differentially Methylated Regions <br> associated with antipsychotic treatment <br> <br> <br> <br> <br> Martens Summer Seminar <br> June 17, 2024 {background-color="black" background-image="img/summerFlowers.jpg" background-size="cover" background-opacity="0.7"}

---

## Looking back over the project <br>

 - Focus on response, rather than cross-sectional methylation status
 - Real-world studies are also challenging - most are short term
 - Median study duration 6 weeks, maximum 13 weeks
 - Treatment discontinuation rate (TDR) lower for monotherapy vs polypharmacy
 - Risperidone highest TDR and shortest Time to discontinuation (TTD)
 


::: footer
Leucht __et al.__ World Psychiatry, 2023; Zhang __et al.__ Frontiers in Pharmacology, 2022
:::

---
#∣ fig-width: 16
#∣ fig-height: 9

![](img/Sample_Selection.png)


::: footer
Martens Summer Seminar June 17, 2024
:::
---

## Antipsychotics <br>

::: {.nonincremental}

-  Acute phase: Often very effective<br>
-  Long term: health problems, cognitive decline,<br> reduced effect<br>
-  Efficacy: D2/D3 receptor antagonism <br>
-  Side effects: multiple receptor targets<br>
-  Therapeutic advances target dopamine/glutamate 

:::


::: footer
Martens Group Retreat

:::


---

## The Synapse in Psychosis





::: footer
Figure: 
:::

---





---


## The Environment and DNAm

{fig-align="center"}

::: footer
Fig. adapted from Tzika, Dreker, Imhof, 2018, ***Frontiers in Genetics***
:::

---


## The Path to Methylation 

{fig-align="center"}




---


## DNA Methylation & Antipsychotics <br> <br>

<p>[Olanzapine, Quetiapine, Risperidone]{.highlight}</p>

::: {.nonincremental}
 

-  Aim 1: To identify common and specific effects on DNA methylation mediated by these APs.

-  Aim 2: Will characterizing variation in methylation contribute to Aim 1? 

:::

::: footer
Martens Summer Seminar June 17, 2024
:::


---


## Methods: Sample Selection {.nostretch}

{width="45%" fig-align="center"}

---

## Methods: Models

Adjustment for both: <br> Age + Sex + Smoking Score + Diagnosis + Technical + eCells

:::: columns
::: {.column width="50%"}
<br>

<p>[Common Effects]{.highlight}</p>

<br>

Quantitative (n=136) <br> <br>

DNAm \~ AP serum values

:::

::: {.column width="50%"}
<br>

<p>[Specific Effects]{.highlight}</p>

<br>

Categorical (n=259) <br> <br>

DNAm \~ AP vs. <br> (2 APs + Med-free)
:::

::::

---

## EWAS and Regional Analyses

:::: columns
::: {.column width="50%"}
<p>[Differentially Methylated (DMRs)]{.highlight}</p>

<br> * Detects mean difference between tissues <br><br> * Parameters: 500 bp, <br> min. 4 CpGs, FDR 0.05
:::

::: {.column width="50%"}
<p>[Variably Methylated (VMRs)]{.highlight}</p>

<br> <br> * Detects difference in variance within a tissue <br><br> * Parameters: 1000 bp, <br> min. 10 CpGs, C2, FDR 0.05
:::

::::

::: footer
R packages: DMRs - *dmrff*, Suderman, 2018,
:::

---

## Results: Common Effects - DMRs

{fig-align="center"}

---

## Results: *SHANK2* <br>

SH3 and multiple ankyrin repeat domains 2 <br><br>

Synaptic Gene Ontologies Database

<p>[GO terms:]{.highlight}</p> 

::: {.nonincremental}

-  postsynaptic density (GO:0014069) <br> 
-  regulation of postsynapse organization (GO:0099175) <br> 
-  structural constituent of postsynaptic density (GO:0098919) <br> <br> 

:::

Using Enrichr for gene set enrichment analysis, we identified significant enrichment of synaptic genes in our dataset. The gene set was sourced from the SynGO 2024 database. 

**Citations:**
- Enrichr: Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. doi:10.1186/1471-2105-14-128.
- SynGO: Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron. 2019;103(2):217-234.e4. doi:10.1016/j.neuron.2019.05.002.

::: footer

https://www.syngoportal.org/

:::

---

## Results: The *SHANK2* DMR

![](img/SerumValues_SHANK2.png)

---

## Results: Common Effects - VMRs<br><br>



:::: footer
Martens Summer Seminar June 17, 2024
:::: 

---

<p>[*TNXB* (Tenascin-XB)]{.highlight}</p> chr6 MHC (class III region)

:::: {layout-ncol=1}




![](img/TNXB_ref.png)


::::

---

## Results: Specific Effects - DMRs<br>

![]{width="60%"}

---

## Results: Specific Effects - VMRs<br>

!{width="60%"}

---

## Conclusion

::: {.incremental}

-  The common effects of APs on ***SHANK2*** expression and glutamate receptor function may be mediated by DNAm. 

-  Identification of the specific effects may need larger sample sizes.  

-  GxE interactions are implicated in up to 75% of VMRs (Epigenomics of Common Diseases 2023). 

:::

::: footer
Martens Summer Seminar June 17, 2024
:::

---

## Acknowledgements

Stéphanie, Anne-Kristin, You all!, Have a great summer!

![](img/Watermelon.jpeg){fig-align="center"}

---
